Colgate-Palmolive Company (NYSE:CL) Shares Sold by ORG Partners LLC

ORG Partners LLC decreased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 6.3% during the 1st quarter, Holdings Channel.com reports. The fund owned 2,008 shares of the company’s stock after selling 136 shares during the period. ORG Partners LLC’s holdings in Colgate-Palmolive were worth $201,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of CL. Brighton Jones LLC raised its stake in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the period. Bernard Wealth Management Corp. bought a new position in Colgate-Palmolive in the 4th quarter worth about $36,000. Private Advisor Group LLC grew its position in Colgate-Palmolive by 12.0% in the 4th quarter. Private Advisor Group LLC now owns 77,231 shares of the company’s stock worth $7,021,000 after purchasing an additional 8,279 shares during the last quarter. Ieq Capital LLC grew its position in Colgate-Palmolive by 25.2% in the 4th quarter. Ieq Capital LLC now owns 58,008 shares of the company’s stock worth $5,274,000 after purchasing an additional 11,666 shares during the last quarter. Finally, Centricity Wealth Management LLC bought a new position in Colgate-Palmolive in the 4th quarter worth about $27,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.4%

Shares of NYSE:CL opened at $87.85 on Friday. The stock has a market capitalization of $71.19 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 4.66 and a beta of 0.38. Colgate-Palmolive Company has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. The company has a 50 day moving average price of $91.50 and a 200 day moving average price of $90.78.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The firm’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period last year, the firm posted $0.86 earnings per share. On average, research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.37%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.76%.

Colgate-Palmolive announced that its Board of Directors has approved a stock buyback plan on Thursday, March 20th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the company to reacquire up to 6.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its shares are undervalued.

Analyst Ratings Changes

Several research analysts have commented on the stock. Citigroup upped their target price on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a “buy” rating in a research report on Monday, April 28th. UBS Group upped their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a “buy” rating in a research report on Thursday, April 17th. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a research report on Wednesday, April 2nd. Barclays decreased their target price on shares of Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating for the company in a research report on Friday, April 11th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an “overweight” rating in a report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $102.12.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.